XTX Topco’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

XTX Topco’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-52,113	Closed	-$7.13K	–	2758
2024 Q2	$7.13K	Buy	52,113 +26,867	+106%	+$4.86K	﹤0.01%	1721
2024 Q1	$3.53K	Sell	25,246 -14,480	-36%	-$2.85K	﹤0.01%	1740
2023 Q4	$5.78K	Buy	+39,726	New	+$6.17K	﹤0.01%	1474
2023 Q3	–	Sell	-53,492	Closed	-$167K	–	2131
2023 Q2	$167K	Buy	+53,492	New	+$159K	0.03%	1072
2022 Q1	–	Sell	-13,499	Closed	-$62K	–	1012
2021 Q4	$62K	Buy	+13,499	New	+$44.6K	0.04%	538

XTX Topco's GRTX Position: Q3 2024 in Review

XTX Topco sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2024, closing a stake of 52,113 shares — an estimated $7.13K sold.

XTX Topco first reported a position in GRTX in Q4 2021 and held it in 5 quarters. The position peaked at $167K in Q2 2023. 0 funds tracked by Wall St. Rank hold GRTX as of Q3 2024.

XTX Topco reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
XTX Topco sold 52,113 Galera Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $7.13K.
XTX Topco first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
XTX Topco's Galera Therapeutics, Inc. Common Stock position peaked at $167K in Q2 2023.
0 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2024.

Based on XTX Topco's 13F filing for Q3 2024, filed 14 Nov 2024.